
Sign up to save your podcasts
Or


Previously, patients could only receive palliative care for symptoms associated with Hunter syndrome, a rare but serious genetic disorder that inhibits the body’s ability to break down specific complex carbohydrates. Now, a new enzyme therapy is making it possible to prevent Hunter syndrome manifestation, typically occurring as early as year two, which dramatically improves long-term quality of life. How quickly do patients show improvement with enzyme therapy? What are the most common side effects? Join host Dr. Mark Nolan Hill for an interesting conversation with Dr. Joseph Muenzer, professor of pediatrics and genetics at the University of North Carolina School of Medicine, and one of the world’s leading experts on Hunter syndrome.
Hunter syndrome is a rare but serious genetic disorder that inhibits the body’s ability to break down specific complex carbohydrates. Initial onset symptoms include inguinal hernias, recurrent otitis, and the common cold, frequently manifesting concurrently as part of a multi-system failure sometime after the first year of life. Because many of these symptoms are common in infants, physicians often do not suspect Hunter syndrome, yet treatment for the disease is much more effective when administered early in its progression. How can we minimize the delay typically associated with diagnosis of Hunter syndrome? Dr. Joseph Muenzer, professor of pediatrics and genetics at the University of North Carolina School of Medicine, and one of the world’s leading authorities in Hunter syndrome research, joins host Dr. Mark Nolan Hill to share his expertise.
Hunter syndrome is a rare but serious genetic disorder that inhibits the body’s ability to break down specific complex carbohydrates. What are the prinicipal symptoms that would lead a primary care physician to consider Hunter syndrome? Dr. Joseph Muenzer, professor of pediatrics and genetics at the University of North Carolina School of Medicine, and one of the world’s leading authorities in Hunter syndrome research, joins host Dr. Mark Nolan Hill to share his expertise.
Dr Ketan Sheth was one of the advisors on the Pediatric Allergies in America survey. This was the largest and most comprehensive national survey of parents of allergy sufferers, allergy sufferers under age 18, and health provider perspectives concerning allergic rhinitis. The survey was designed using the same methods and many of the same measures as Allergies in America (2006). A number of important conclusions about the current state of nasal allergies among American children are:
The findings from the Pediatrics Allergies in America survey identify important challenges …
Dr. Fernando Burstein shares his experience in managing a large multi-disciplinary team to help correct a cleft lip and cleft palate. How does the team approach work in a complex series of multiple surgeries? What are the critical success factors in planning and executing surgeries with multiple medical diciplines involved? Join host Dr. Mark Nolan Hill to learn more.
Dr. Michael Greenberg speaks with Dr. Hugh Rienhoff about www.mydaughtersdna.org, a website he created to help children with rare or difficult-to-diagnose genetic diseases find proper diagnoses and help.
For our young patients with diabetes, there is a lollipop lurking around every corner. Many of us never give a second thought to the pervasiveness of sweets and snacks in our culture. Until a child is diagnosed, of course. James Hirsch, author of “Cheating Destiny," joins host Dr. Leslie Lundt to review advice you can give to parents raising a child with diabetes in today’s world.
Dr. Beth A. Tarini, clinical lecturer in the Child Health Evaluation and Research Unit at the University of Michigan C.S. Mott Children's Hospital in Ann Arbor, discusses the application of tandem mass spectrometry in newborn screening with host Susan Dolan.